Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""clindamycin"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 8032
Tytuł:
Structure-Activity Relationship Target Prediction Studies of Clindamycin Derivatives with Broad-Spectrum Bacteriostatic Antibacterial Properties.
Autorzy:
Jia Y; School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430073, China.
Zhang Y; School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430073, China.
Zhu H; School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430073, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Oct 31; Vol. 28 (21). Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:
Journal Article
MeSH Terms:
Clindamycin*/pharmacology
Bacterial Infections*/microbiology
Humans ; Molecular Docking Simulation ; Bacterial Proteins/metabolism ; Anti-Bacterial Agents/pharmacology ; Structure-Activity Relationship ; Microbial Sensitivity Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Potential Clinically Relevant Effects of Sialylation on Human Serum AAG-Drug Interactions Assessed by Isothermal Titration Calorimetry: Insight into Pharmacoglycomics?
Autorzy:
Kerep R; Department of General and Inorganic Chemistry, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
Šeba T; Department of General and Inorganic Chemistry, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
Borko V; Department of General and Inorganic Chemistry, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
Weitner T; Department of General and Inorganic Chemistry, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
Keser T; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
Lauc G; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
Gabričević M; Department of General and Inorganic Chemistry, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 09; Vol. 24 (10). Date of Electronic Publication: 2023 May 09.
Typ publikacji:
Journal Article
MeSH Terms:
Warfarin*/pharmacology
Clindamycin*
Humans ; Protein Binding ; Diltiazem ; Calorimetry/methods ; Orosomucoid/metabolism ; Thermodynamics ; Drug Interactions
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Antimicrobial Resistance Patterns in Patients with Vaginal Discharge: A 2019-2022 Analysis at the National Health Laboratory in Eritrea.
Autorzy:
Hussein K; Department of Obstetrics and Gynecology, Orotta College of Medicine and Health Sciences, Orotta National Referral Maternity Hospital, Ministry of Health, Asmara, Eritrea.
Tesfai B; Department of Obstetrics and Gynecology, Orotta College of Medicine and Health Sciences, Orotta National Referral Maternity Hospital, Ministry of Health, Asmara, Eritrea.
Frezgi O; Department of Obstetrics and Gynecology, Orotta College of Medicine and Health Sciences, Orotta National Referral Maternity Hospital, Ministry of Health, Asmara, Eritrea.
Hayelom H; Microbiology Department, National Health Laboratory, Ministry of Health, Asmara, Eritrea.
Gebremeskel Y; Microbiology Department, National Health Laboratory, Ministry of Health, Asmara, Eritrea.
Werede A; National Medicines and Food Administration, Ministry of Health, Asmara, Eritrea.
Gebremariam H; Dekemhare Hospital, Zoba Debub, Ministry of Health, Dekemhare, Eritrea.
Kibreab F; Ministry of Health, Division of the Center for Health Research and Resources, Asmara, Eritrea.
Hamida ME; Unit of Medical Microbiology, Orotta College of Medicine and Health Sciences, Asmara, Eritrea.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2024 Mar 28; Vol. 2024, pp. 7193490. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Bacterial Agents*/pharmacology
Anti-Bacterial Agents*/therapeutic use
Vaginal Discharge*
Female ; Humans ; Clindamycin ; Vancomycin ; Trimethoprim, Sulfamethoxazole Drug Combination ; Staphylococcus aureus ; Escherichia coli ; Eritrea ; Rifampin ; Retrospective Studies ; Drug Resistance, Bacterial ; Oxacillin ; Gram-Positive Bacteria ; Tetracycline/pharmacology ; Streptococcus ; Ampicillin ; Penicillin G ; Microbial Sensitivity Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Macrolide and lincosamide resistance of Streptococcus agalactiae in pregnant women in Poland.
Autorzy:
Kamińska D; Chair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Ratajczak M; Chair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Nowak-Malczewska DM; Chair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Karolak JA; Chair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Kwaśniewski M; Chair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Szumala-Kakol A; Unit of Microbiology, Gynecological and Obstetric Clinical Hospital, Poznan University of Medical Sciences, Polna 33, 60-535, Poznan, Poland.
Dlugaszewska J; Chair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Gajecka M; Chair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland. .; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 16; Vol. 14 (1), pp. 3877. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Bacterial Agents*/pharmacology
Streptococcal Infections*/drug therapy
Streptococcal Infections*/epidemiology
Infant, Newborn ; Female ; Humans ; Pregnancy ; Macrolides/pharmacology ; Streptococcus agalactiae ; Clindamycin/pharmacology ; Pregnant Women ; Poland/epidemiology ; Drug Resistance, Bacterial/genetics ; Microbial Sensitivity Tests ; Lincosamides/pharmacology ; Erythromycin/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Canine Pyothorax: Comparison of Culture and Susceptibility Results to the BSAVA PROTECT ME Poster and Other Published Recommended Antimicrobial Use Guidelines.
Autorzy:
Heinsoo, Iris (AUTHOR)
Walker, David J. (AUTHOR)
Bergum Hjellegjerde, Kine (AUTHOR)
Tang, Julia W. Y. (AUTHOR)
Moores, Alison L. (AUTHOR)
Pokaż więcej
Źródło:
Animals (2076-2615). Dec2023, Vol. 13 Issue 24, p3843. 12p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats.
Autorzy:
Álvarez-Pérez, Sergio (AUTHOR)
Anega, Blanca (AUTHOR)
Blanco, José L. (AUTHOR)
Hernández, Marta (AUTHOR)
García, Marta E. (AUTHOR)
Pokaż więcej
Źródło:
BMC Veterinary Research. 11/16/2023, Vol. 19 Issue 1, p1-6. 6p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Microbiological and clinical characteristics of invasive Group B Streptococcal blood stream infections in children and adults from Qatar.
Autorzy:
Ali M; Communicable Diseases Centre, Infectious Diseases Department, Hamad Medical Corporation, P. O. Box 3050, Doha, Qatar. .
Alamin MA; Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
A Ali G; Communicable Diseases Centre, Infectious Diseases Department, Hamad Medical Corporation, P. O. Box 3050, Doha, Qatar.
Alzubaidi K; Paediatric Infectious Diseases, Sidra Medicine, Doha, Qatar.
Ali B; Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Ismail A; Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Daghfal J; Communicable Diseases Centre, Infectious Diseases Department, Hamad Medical Corporation, P. O. Box 3050, Doha, Qatar.
Almaslamani M; Communicable Diseases Centre, Infectious Diseases Department, Hamad Medical Corporation, P. O. Box 3050, Doha, Qatar.
Hadi HA; Communicable Diseases Centre, Infectious Diseases Department, Hamad Medical Corporation, P. O. Box 3050, Doha, Qatar.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2022 Nov 24; Vol. 22 (1), pp. 881. Date of Electronic Publication: 2022 Nov 24.
Typ publikacji:
Journal Article
MeSH Terms:
Clindamycin*
Streptococcal Infections*/drug therapy
Streptococcal Infections*/epidemiology
Streptococcal Infections*/microbiology
Pregnancy ; Child ; Young Adult ; Female ; Humans ; Aged ; Child, Preschool ; Male ; Ceftriaxone ; Vancomycin ; Retrospective Studies ; Qatar/epidemiology ; Microbial Sensitivity Tests ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Streptococcus agalactiae ; Erythromycin/pharmacology ; Erythromycin/therapeutic use ; Penicillins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pathogenicity assessment of Arcobacter butzleri isolated from Canadian agricultural surface water.
Autorzy:
Khan IUH; Ottawa Research and Development Centre (ORDC), Agriculture and Agri-Food Canada, 960 Carling Ave, Ottawa, ON, K1A 0C6, Canada. .
Chen W; Ottawa Research and Development Centre (ORDC), Agriculture and Agri-Food Canada, 960 Carling Ave, Ottawa, ON, K1A 0C6, Canada.
Cloutier M; Ottawa Research and Development Centre (ORDC), Agriculture and Agri-Food Canada, 960 Carling Ave, Ottawa, ON, K1A 0C6, Canada.
Lapen DR; Ottawa Research and Development Centre (ORDC), Agriculture and Agri-Food Canada, 960 Carling Ave, Ottawa, ON, K1A 0C6, Canada.
Craiovan E; Ottawa Research and Development Centre (ORDC), Agriculture and Agri-Food Canada, 960 Carling Ave, Ottawa, ON, K1A 0C6, Canada.
Wilkes G; Ottawa Research and Development Centre (ORDC), Agriculture and Agri-Food Canada, 960 Carling Ave, Ottawa, ON, K1A 0C6, Canada.; Natural Resources Canada, Ottawa, ON, Canada.
Pokaż więcej
Źródło:
BMC microbiology [BMC Microbiol] 2024 Jan 08; Vol. 24 (1), pp. 17. Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:
Journal Article
MeSH Terms:
Arcobacter*/genetics
Animals ; Humans ; Canada ; Azithromycin ; Clindamycin ; Virulence ; Nalidixic Acid/pharmacology ; Chloramphenicol ; Enterobacteriaceae
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Application of the U.S. Food and Drug Administration's Sentinel Routine Querying Tools to the Taiwan Sentinel Data Model-formatted National Health Insurance Research Database.
Autorzy:
Lin FJ; Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University Hospital, Taipei, Taiwan.; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
Huang LY; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
Wang CC; Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University Hospital, Taipei, Taiwan.; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
Toh S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Pokaż więcej
Źródło:
Journal of food and drug analysis [J Food Drug Anal] 2023 Dec 15; Vol. 31 (4), pp. 772-781.
Typ publikacji:
Journal Article
MeSH Terms:
Hypoglycemia*/chemically induced
Angioedema*/chemically induced
Angioedema*/epidemiology
United States ; Humans ; Pharmaceutical Preparations ; Warfarin ; Clindamycin ; Glyburide ; United States Food and Drug Administration ; Taiwan ; Angiotensin-Converting Enzyme Inhibitors ; Gastrointestinal Hemorrhage/chemically induced
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Species- and strain-level diversity of Corynebacteria isolated from human facial skin.
Autorzy:
Jensen MG; Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
Svraka L; Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
Baez E; Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
Lund M; Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
Poehlein A; Department of Genomic and Applied Microbiology, Institute of Microbiology and Genetics, University of Göttingen, Göttingen, Germany.
Brüggemann H; Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus, Denmark. .
Pokaż więcej
Źródło:
BMC microbiology [BMC Microbiol] 2023 Nov 28; Vol. 23 (1), pp. 366. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Journal Article
MeSH Terms:
Corynebacterium*/genetics
Skin*/microbiology
Humans ; Pilot Projects ; Anti-Bacterial Agents/pharmacology ; Clindamycin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study.
Autorzy:
Molinelli E; Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Brisigotti V; Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Simonetti O; Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Sapigni C; Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
D'Agostino GM; Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Rizzetto G; Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Giacchetti A; Dermatological Unit, Institute for Treatment and Research (INRCA IRCCS), Ancona, Italy.
Offidani A; Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Jun; Vol. 35 (6), pp. e15439. Date of Electronic Publication: 2022 Mar 18.
Typ publikacji:
Journal Article
MeSH Terms:
Clindamycin*/adverse effects
Hidradenitis Suppurativa*/chemically induced
Hidradenitis Suppurativa*/diagnosis
Hidradenitis Suppurativa*/drug therapy
Anti-Bacterial Agents/adverse effects ; Humans ; Resorcinols/adverse effects ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Is clindamycin a potential treatment for prostatitis?
Autorzy:
Ritter L; College of Pharmacy, University of Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil.
Bergoza L; College of Pharmacy, University of Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil.
Possa E; College of Pharmacy, University of Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil.
Tasso L; College of Pharmacy, University of Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil.; Laboratory of Pharmacokinetics, Health Sciences Postgraduate Program and Biotechnology Postgraduate Program, University of Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil.
Pokaż więcej
Źródło:
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2022 Apr; Vol. 130 (4), pp. 197-205. Date of Electronic Publication: 2022 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Clindamycin*/pharmacology
Clindamycin*/therapeutic use
Prostatitis*/drug therapy
Animals ; Anti-Bacterial Agents/pharmacology ; Male ; Microbial Sensitivity Tests ; Prostate ; Rats
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of 3-day low dose quinine plus clindamycin versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial.
Autorzy:
Obonyo CO; Centre for Global Health Research, Kenya Medical Research Institute, P.O. Box 1578, Kisumu, Kenya. .
Juma EA; Centre for Clinical Research, Kenya Medical Research Institute, P.O. Box 20778, Nairobi, Kenya.
Were VO; Centre for Global Health Research, Kenya Medical Research Institute, P.O. Box 1578, Kisumu, Kenya.
Ogutu BR; Centre for Clinical Research, Kenya Medical Research Institute, P.O. Box 20778, Nairobi, Kenya.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2022 Feb 02; Vol. 21 (1), pp. 30. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Artemether, Lumefantrine Drug Combination/*therapeutic use
Clindamycin/*therapeutic use
Malaria, Falciparum/*drug therapy
Quinine/*therapeutic use
Artemether, Lumefantrine Drug Combination/adverse effects ; Child, Preschool ; Clindamycin/adverse effects ; Drug Therapy, Combination ; Female ; Humans ; Infant ; Kenya ; Male ; Quinine/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluating antibiotic regimens for streptococcal toxic shock syndrome in children.
Autorzy:
Zhang H; Department of Pharmacy, Hunan Children's Hospital, Changsha, China.
Dong J; Pediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, China.
Huang J; Department of Intensive Care Medicine, Hunan Children's Hospital, Changsha, China.
Zhang K; School of Medicine, Hunan Normal University, Changsha, China.
Lu X; Department of Intensive Care Medicine, Hunan Children's Hospital, Changsha, China.
Zhao X; Department of Pharmacy, Hunan Children's Hospital, Changsha, China.
Xiao C; Department of Pharmacy, Chenzhou First People's Hospital, Chenzhou, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Oct 12; Vol. 18 (10), pp. e0292311. Date of Electronic Publication: 2023 Oct 12 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Shock, Septic*/drug therapy
Streptococcal Infections*/drug therapy
Humans ; Child ; Anti-Bacterial Agents/therapeutic use ; Clindamycin/therapeutic use ; Retrospective Studies ; Streptococcus pyogenes ; Penicillins/therapeutic use ; Ampicillin/therapeutic use ; Protein Synthesis Inhibitors/therapeutic use ; Macrolides/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition.
Autorzy:
Larsen IS; Novozymes A/S, Bagsværd, Denmark.
Chenaux M; Novozymes Inc, Davis, CA, USA.
Collins FWJ; PrecisionsBiotics Group, Cork, Ireland.
Mandic A; Novozymes GmbH, Berlin, Germany.
Hansen LBS; Novozymes A/S, Bagsværd, Denmark.
Lauridsen CAS; Novozymes A/S, Bagsværd, Denmark.
Haller RF; Novozymes A/S, Bagsværd, Denmark.
Elvig-Jørgensen S; Novozymes A/S, Bagsværd, Denmark.
Horwell E; Bioscience Innovation Centre, Sporegen Ltd., 2 Royal College Street, London, NW1 0NH, UK.
Christiansen J; Novozymes A/S, Bagsværd, Denmark.
Silva A; Novozymes A/S, Bagsværd, Denmark.
Vehreschild MJGT; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.
Cutting SM; Bioscience Innovation Centre, Sporegen Ltd., 2 Royal College Street, London, NW1 0NH, UK.; Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey, UK.
Roggenbuck-Wedemeyer M; Novozymes A/S, Bagsværd, Denmark.
Kristensen NN; Novozymes A/S, Bagsværd, Denmark. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 11; Vol. 13 (1), pp. 14941. Date of Electronic Publication: 2023 Sep 11.
Typ publikacji:
Journal Article
MeSH Terms:
Gastrointestinal Microbiome*
Clostridioides difficile*
Humans ; Animals ; Mice ; Clindamycin/pharmacology ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Clostridioides
SCR Organism:
Bacillus velezensis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Decreased susceptibility to vancomycin and other mechanisms of resistance to antibiotics in Staphylococcus epidermidis as a therapeutic problem in hospital treatment.
Autorzy:
Szemraj M; Department of Pharmaceutical Microbiology and Microbiological Diagnostic, Medical University of Lodz, Lodz, Poland. .
Glajzner P; Department of Pharmaceutical Microbiology and Microbiological Diagnostic, Medical University of Lodz, Lodz, Poland.
Sienkiewicz M; Department of Pharmaceutical Microbiology and Microbiological Diagnostic, Medical University of Lodz, Lodz, Poland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 21; Vol. 13 (1), pp. 13629. Date of Electronic Publication: 2023 Aug 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Bacterial Agents*/pharmacology
Anti-Bacterial Agents*/therapeutic use
Vancomycin*/pharmacology
Vancomycin*/therapeutic use
Staphylococcus epidermidis/genetics ; Clindamycin ; Staphylococcus ; Hospitals
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Arterial leg ulcers-Bacterial patterns, antimicrobial resistance and clinical characteristics, a retrospective single-centre cohort, 2012-2021.
Autorzy:
Salm J; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Böhme T; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Noory E; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Beschorner U; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Kramer TS; Charité -Universitätsmedizin Berlin, Institute for Hygiene and Environmental Medicine, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; LADR der Laborverbund Dr. Kramer & Kollegen, Geesthacht, Germany.
Westermann D; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Zeller T; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Aug 11; Vol. 18 (8), pp. e0290103. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Staphylococcal Infections*/drug therapy
Leg Ulcer*
Humans ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Clindamycin/therapeutic use ; Staphylococcus aureus ; Escherichia coli ; Retrospective Studies ; Drug Resistance, Bacterial ; Bacteria ; Ciprofloxacin/therapeutic use ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use ; Microbial Sensitivity Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety comparison of combination of 0.04% tretinoin microspheres plus 1% clindamycin versus their monotherapy in patients with acne vulgaris: a phase 3, randomized, double-blind study.
Autorzy:
Dogra S; Department of Dermatology, Venereology & Leprology, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
Sumathy TK; Department of Dermatology, M.S. Ramaiah Medical College and Hospital, Bengaluru, India.
Nayak C; Department of Dermatology, BYL Nair CH Hospital & TNMC, Mumbai, India.
Ravichandran G; Department of Dermatology, Apollo Hospitals, Chennai, India.
Vaidya PP; Department of Dermatology, Apollo Jehangir Hospital, Pune, India.
Mehta S; Medical Affairs Division, Dr Reddy's Laboratories Ltd, Hyderabad, India.
Mittal R; Medical Affairs Division, Dr Reddy's Laboratories Ltd, Hyderabad, India.
Mane A; Medical Affairs Division, Dr Reddy's Laboratories Ltd, Hyderabad, India.
Charugulla SN; Medical Affairs Division, Dr Reddy's Laboratories Ltd, Hyderabad, India.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2021 Dec; Vol. 32 (8), pp. 925-933. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Acne Vulgaris*/drug therapy
Clindamycin*/adverse effects
Double-Blind Method ; Drug Combinations ; Gels ; Humans ; Microspheres ; Treatment Outcome ; Tretinoin/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 8032

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies